Related Experiment Video

Updated: Sep 28, 2026

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
06:54

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells

Published on: October 27, 2020

Restoration of transforming growth factor Beta signaling by functional expression of smad4 induces anoikis

Murali Ramachandra1, Isabella Atencio, Amena Rahman

  • 1Canji, Inc., San Diego, California 92121, USA. murali.ramachandra@canji.com

Cancer Research
|November 5, 2002
PubMed

Insights

Smad4 protein restoration in cancer cells re-established transforming growth factor beta (TGF-beta) signaling, inducing anoikis (apoptosis upon detachment) and suppressing tumor growth. This suggests Smad4

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Smad proteins are key mediators of transforming growth factor beta (TGF-beta) signaling, crucial for cell proliferation and differentiation.
  • Smad4 (DPC4) is a tumor suppressor gene frequently inactivated in pancreatic carcinomas, indicating its role in malignancy.

Purpose of the Study:

  • To functionally characterize Smad4 and its role in TGF-beta signaling restoration.
  • To investigate the impact of Smad4 expression on cancer cell behavior, including proliferation, apoptosis, and anoikis.

Main Methods:

  • Generated a recombinant adenovirus (Ad-Smad4) to express Smad4 in Smad4-null breast carcinoma cells (MDA-MB-468).
  • Assessed TGF-beta signaling restoration via plasminogen activator inhibitor 1 promoter activity and p21 expression.
  • Evaluated cell morphology, beta1 integrin expression, colony formation, cell cycle progression, and apoptosis induction (including anoikis).

Main Results:

  • Ad-Smad4 expression restored TGF-beta signaling, evidenced by increased plasminogen activator inhibitor 1 promoter activity and p21 expression.
  • Smad4 expression altered cell morphology, increased beta1 integrin, reduced soft agar colony formation, and caused a modest S phase reduction.
  • Smad4 expression induced TGF-beta-dependent anoikis in detached cells, involving increased focal adhesion kinase 2 (Pyk2) and caspase activation.

Conclusions:

  • Restoration of Smad4 and TGF-beta signaling induces anoikis in cancer cells, a process that may prevent metastasis.
  • Defects in Smad4 function are functionally linked to malignancy development, potentially through resistance to anoikis.
  • Smad4 plays a critical role in regulating anoikis and suppressing tumor progression.

More Related Videos

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System11:06

Live Cell Imaging of the TGF- β/Smad3 Signaling Pathway In Vitro and In Vivo Using an Adenovirus Reporter System

Published on: July 30, 2018

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...